The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review.

Dryden, Carol

The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review. [electronic resource] - Archives of disease in childhood 01 2018 - 68-70 p. digital

Publication Type: Journal Article; Review

1468-2044

10.1136/archdischild-2015-310420 doi


Aminophenols--therapeutic use
Child
Chloride Channel Agonists--therapeutic use
Cystic Fibrosis--drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator--genetics
Humans
Mutation
Quinolones--therapeutic use
Scotland
Treatment Outcome